HUMA - Humacyte to Present 2023 Fourth Quarter and Year-End Financial Results and Provide Corporate Update on March 22 2024 | Benzinga
DURHAM, N.C., March 18, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will release its financial results for the fourth quarter and year ended December 31, 2023, on Friday, March 22, 2024. Management will host a webcast and conference call at 8:00 a.m. ET to provide a corporate and financial update.
| Title: |
| Humacyte Fourth Quarter and Year-End 2024 Earnings Conference Call |
| Date: |
| March 22, 2024 |
| Time |
| 8:00 AM Eastern Time |
| Conference Call Details |
| 1-877-704-4453 (U.S. Investors Dial) 1-201-389-0920 (International Investors Dial) 13744046 (Conference ID) |
| Call meTMFeature |